The Liver Meeting 2019-Cost Effectiveness of Screening and Linkage to Care

Cost Effectiveness of Screening and Linkage to Care

Video Transcription

Video Summary

The speaker discusses cost-effectiveness analysis, specifically focusing on screening for liver diseases like hepatitis C and non-alcoholic liver disease. They explain the methods and goals of cost-effectiveness analysis, comparing different screening strategies and their potential benefits. The speaker presents data on the cost-effectiveness of universal screening for hepatitis C in the US, as well as in countries like Pakistan. They also touch on the challenges of linking patients to care after screening and the need for national policies to address these issues. Additionally, the speaker addresses the concept of lean NAFLD in Asian populations and the importance of early detection and management to prevent disease progression. Overall, the discussion highlights the complexities of implementing effective screening programs for liver diseases and the need for collaborative efforts to improve outcomes.

Asset Caption

Presenter: Fasiha Kanwal

Keywords

cost-effectiveness analysis

screening

liver diseases

hepatitis C

non-alcoholic liver disease

universal screening

national policies